Norovirus in immunocompromised patients

Oncology Nursing Forum

Volumn 40, Issue 5, 2013, Pages 434-436

  Atmar, Jill ^a   Mullen, Ellen ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIARRHEAL AGENT; ANTINEOPLASTIC AGENT; BENDAMUSTINE; CHLORMETHINE DERIVATIVE; MITOXANTRONE; MONOCLONAL ANTIBODY; RITUXIMAB;

ABDOMINAL PAIN; AGED; ARTICLE; CALICIVIRUS INFECTION; CASE REPORT; DISEASE TRANSMISSION; DISINFECTION; FEMALE; FLUID THERAPY; FOLLICULAR LYMPHOMA; GASTROENTERITIS; GENETICS; HAND WASHING; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; INCIDENCE; INFECTION CONTROL; ISOLATION AND PURIFICATION; METHODOLOGY; MULTIMODALITY CANCER THERAPY; NOROVIRUS; PATHOGENICITY; VIROLOGY; VIRUS SHEDDING;

ABDOMINAL PAIN; AGED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIDIARRHEALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CALICIVIRIDAE INFECTIONS; COMBINED MODALITY THERAPY; DISINFECTION; FEMALE; FLUID THERAPY; GASTROENTERITIS; HAND DISINFECTION; HUMANS; IMMUNOCOMPROMISED HOST; INCIDENCE; INFECTION CONTROL; LYMPHOMA, FOLLICULAR; MITOXANTRONE; NITROGEN MUSTARD COMPOUNDS; NOROVIRUS; VIRUS SHEDDING;

EID: 84893062724     PISSN: 0190535X     EISSN: 15380688     Source Type: Journal    
DOI: 10.1188/13.ONF.434-436     Document Type: Article

References (12)

1. Atmar, R., Bernstein, D., Harro, C., Al-Ibrahim, M., Chen, S., Ferreira, J., Mendelman, P. (2011). Norovirusvaccine against experimental human Norwalk virus illness. New England Journal of Medicine, 365, 2178-2187.
2. Atmar, R., & Estes, M.K. (2006). The epi-demiologic and clinical importance of norovirus infection. Gastroenterology Clinics of North America, 35, 275-290. doi:10.1016/i.gtc.2006.03.001
3. Atmar, R., Opekun, A., Gilger, M., Estes, M.K., Crawford, S., Neill, F., & Graham, D. (2008). Norwalk virus shedding after experimental human infection. Emerging Infectious Diseases, 14, 1-5. doi:10.3201/eid1410.080117
4. Estes, M.K., Prasad, B.V., & Atmar, R. (2006). Noroviruses everywhere: Has something changed? Current Opinions in Infectious Disease, 19, 467-474.
5. Glass, R., Parashar, U., & Estes, M.K., (2010). Norovirus gastroenteritis. New England Journal of Medicine, 361, 1776-1785.
6. Hall, A., Vinje, J., Lopman, B., Park, G., Yen, C., Gregoricus, N., & Parashar, U. (2011). Updated norovirus outbreak management and disease prevention guidelines. Morbidity and Mortality Weekly Report, 60(3), 1-15.
7. Healthcare Infection Control Practices Advisory Committee. (2011). Guidelines for the prevention and control of norovirus gastroenteritis outbreaks. Retrieved from http://1.usa.gov/jSCQbw
8. Kaplan, J.E., Feldman, R., Campbell, D.S., Lookabaugh, C., & Gary, G.W. (1982). The frequency of a Norwalk-like pattern of illness in outbreaks of acute gastroenteritis. American Journal of Public Health, 72, 1329-1332.
9. Koo, H., Ajami, N., Atmar, R., & DuPont, H. (2010). Noroviruses: The leading cause of gastroenteritis worldwide. Discovery Medicine, 87(10), 61-70.
10. Patel, M., Hall, A., Vinje, J., & Parashar, U. (2009). Noroviruses: A comprehensive review. Journal of Clinical Virology, 44, 1-8.
11. Roddie, C., Paul, P., Benjamin, P., Gallimore, C., Xerry, J., Gray, J., Ward, K.N. (2009). Allogeneic hematopoietic stem cell tansplantation and norovirus gastroenteritis. Clinical Infectious Diseases, 49, 1061-1068.
12. Scallan, C., Hoestra, R.M., Angelo, F.J., Tauxe, R.V., Willowson, M.A., Roy, S.L., Griffin, P.M. (2011). Foodborne illness acquired in the United States. Emerging Infectious Diseases, 17, 7-15.